Additionally, we found that treatment of MCC cell lines with various small-molecule inhibitors, such as Bcl-2 inhibitors, epigenetic modifiers, BET degraders, and ADCs, has facilitated apoptosis and tumor volume reduction in MCC mouse xenograft models. The gene discussed is BCL2; the disease is Merkel cell skin cancer.